Clinical trial INCB 01158-203
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors. (INCB01158-203)
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| EudraCT Identifier | 2017-002904-29 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03314935 |
| Inclusion criteria | Metastatic Biopsy mandatory |
| Last update |